BRIEF-Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives

Reuters

Sep 20, 2024

Sept 19 (Reuters) - Notable Labs Ltd :

* NOTABLE LABS LTD - APPROVED A STREAMLINED OPERATING PLAN WHICH INCLUDES EXPLORING STRATEGIC ALTERNATIVES

* NOTABLE LABS LTD - APPROVED IMMEDIATELY PAUSING IMPLEMENTATION OF PLANNED PHASE 2 STUDY OF VOLASERTIB IN RELAPSED/REFRACTORY AML (R/R AML)

* NOTABLE LABS LTD - APPROVED REDUCTION IN CO'S EMPLOYEE WORKFORCE AND OUTSIDE CONSULTANTS BY ABOUT 65%

* NOTABLE LABS LTD - ANTICIPATES RECOGNIZING APPROXIMATELY $0.1 MILLION IN TOTAL CHARGES IN CONNECTION WITH REDUCTION IN FORCE

Source text for Eikon: Further company coverage:

(Reuters.Briefs@thomsonreuters.com)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2468879616"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2468879616\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2468879616?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-20 04:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2468879616","market":"us","top_or_hot":-1,"title":"BRIEF-Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives","media":"Reuters","content":"<html><body><p>Sept 19 (Reuters) - Notable Labs Ltd   :</p><p>   * NOTABLE LABS LTD - APPROVED A STREAMLINED OPERATING PLAN WHICH INCLUDES EXPLORING STRATEGIC ALTERNATIVES</p><p>   * NOTABLE LABS LTD - APPROVED IMMEDIATELY PAUSING IMPLEMENTATION OF PLANNED PHASE 2 STUDY OF VOLASERTIB IN RELAPSED/REFRACTORY AML (R/R AML)</p><p>   * NOTABLE LABS LTD - APPROVED REDUCTION IN CO'S EMPLOYEE WORKFORCE AND OUTSIDE CONSULTANTS BY ABOUT 65%</p><p>   * NOTABLE LABS LTD - ANTICIPATES RECOGNIZING APPROXIMATELY $0.1 MILLION IN TOTAL CHARGES IN CONNECTION WITH REDUCTION IN FORCE</p><p>Source text for Eikon:    Further company coverage:   </p><p> (Reuters.Briefs@thomsonreuters.com)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-09-20 04:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Sept 19 (Reuters) - Notable Labs Ltd   :</p><p>   * NOTABLE LABS LTD - APPROVED A STREAMLINED OPERATING PLAN WHICH INCLUDES EXPLORING STRATEGIC ALTERNATIVES</p><p>   * NOTABLE LABS LTD - APPROVED IMMEDIATELY PAUSING IMPLEMENTATION OF PLANNED PHASE 2 STUDY OF VOLASERTIB IN RELAPSED/REFRACTORY AML (R/R AML)</p><p>   * NOTABLE LABS LTD - APPROVED REDUCTION IN CO'S EMPLOYEE WORKFORCE AND OUTSIDE CONSULTANTS BY ABOUT 65%</p><p>   * NOTABLE LABS LTD - ANTICIPATES RECOGNIZING APPROXIMATELY $0.1 MILLION IN TOTAL CHARGES IN CONNECTION WITH REDUCTION IN FORCE</p><p>Source text for Eikon:    Further company coverage:   </p><p> (Reuters.Briefs@thomsonreuters.com)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NTBL","symbol_name":"Notable Labs Inc.","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2468879616","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2468879616","pubTimestamp":1726776659,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Sept 19 (Reuters) - Notable Labs Ltd   :   * NOTABLE LABS LTD - APPROVED A STREAMLINED OPERATING PLAN WHICH INCLUDES EXPLORING STRATEGIC ALTERNATIVES   * NOTABLE LABS LTD - APPROVED IMMEDIATELY PAUSIN","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"NTBL":"Notable Labs Inc."},"translate_title":"简介-著名实验室批准了一项简化的运营计划，其中包括探索战略替代方案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NTBL":0.9},"content_text":"Sept 19 (Reuters) - Notable Labs Ltd   :   * NOTABLE LABS LTD - APPROVED A STREAMLINED OPERATING PLAN WHICH INCLUDES EXPLORING STRATEGIC ALTERNATIVES   * NOTABLE LABS LTD - APPROVED IMMEDIATELY PAUSING IMPLEMENTATION OF PLANNED PHASE 2 STUDY OF VOLASERTIB IN RELAPSED/REFRACTORY AML (R/R AML)   * NOTABLE LABS LTD - APPROVED REDUCTION IN CO'S EMPLOYEE WORKFORCE AND OUTSIDE CONSULTANTS BY ABOUT 65%   * NOTABLE LABS LTD - ANTICIPATES RECOGNIZING APPROXIMATELY $0.1 MILLION IN TOTAL CHARGES IN CONNECTION WITH REDUCTION IN FORCESource text for Eikon:    Further company coverage:    (Reuters.Briefs@thomsonreuters.com)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}